Medical Metrics, Inc. Achieves ISO 9001:2008 Certification for Imaging Core Lab Services

HOUSTON--(BUSINESS WIRE)-- Medical Metrics, Inc. (MMI) announces that it has successfully achieved ISO 9001:2008 certification of its Quality Management System in support of imaging core lab services for orthopedic, spine, cardiovascular and neurological clinical trials. This certification demonstrates MMI’s commitment to meeting the highest standards for quality, regulatory compliance, customer satisfaction, and continuous improvement.

Tom Martin, President and CEO of Medical Metrics, commented: "Our successful conformance to the ISO 9001:2008 standard affirms our pursuit of continuous improvement and our commitment to exceed the expectations of our clients. Few imaging core labs have completed the rigorous requirements for ISO certification. Our adherence to the standard will serve as yet another mechanism to ensure delivery of timely, high-quality services to our clients.”

The ISO certification (certificate no. 46605) was issued by ABS Quality Evaluations, Inc., an accredited registrar that performs assessments of quality management systems per the exacting requirements of national and international standards for quality.

About Medical Metrics

Medical Metrics, Inc. (MMI) is an experienced provider of independent imaging core lab services for clinical trials of medical devices, drugs, and biologics. For more than 10 years, MMI has partnered with clinical trial sponsors to conduct comprehensive imaging evaluations of treatments for musculoskeletal, cardiovascular, and neurological disorders. Trials range from pre-clinical and early-phase clinical testing to pivotal studies and post-approval surveillance. With an ISO-certified quality management system, 510k-cleared image management platform, and core group of radiology and cardiology thought leaders, MMI is uniquely positioned to deliver high-quality image management and review services for global clinical trials. For more information, please visit


Medical Metrics, Inc.
Michelle Council, 281-851-9802 x211
Director of Business Development
[email protected]

KEYWORDS:   United States  North America  Texas

INDUSTRY KEYWORDS:   Surgery  Health  Clinical Trials  Medical Devices  Research  Science



Suggested Articles

Health insurance startup Bind scored a $105 million series B funding round backed by Ascension Ventures and UnitedHealth.

The Food and Drug Administration has granted breakthrough designation to AppliedVR's platform that treats chronic lower back pain.

Here's how the COVID-19 pandemic changed healthcare executives' focus on technology and what to expect in 2021.